EUVIMEDEUVIMED entdecken
Crossref

A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications

Jean-Pierre Changeux iD, Zahir Amoura iD, Felix A Rey, Makoto Miyara

Comptes Rendus. Biologies · 05.06.2020 · 343 (1) · 33-39

DOI: 10.5802/crbiol.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comptes Rendus. Biologies, online erschienen am 05.06.2020. Verfasst von Jean-Pierre Changeux und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur CNRS UMR 3571 Department of Neuroscience and Collège de France, Paris France. Hauptthemen laut MEDLINE: Receptors, Nicotinic. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 epidemics raises a considerable issue of public health at the planetary scale. There is a pressing urgency to find treatments based upon currently available scientific knowledge. Therefore, we tentatively propose a hypothesis which hopefully might ultimately help save lives. Based on the current scientific literature and on new epidemiological data which reveal that current smoking status appears to be a protective factor against the infection by SARS-CoV-2 [1], we hypothesize that the nicotinic acetylcholine receptor (nAChR) plays a key role in the pathophysiology of Covid-19 infection and might represent a target for the prevention and control of Covid-19 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, NicotinicCOVID-19Coronavirus InfectionsHumansNicotineNicotinic AgonistsPandemicsPneumonia, ViralSmokingTransdermal Patch

Stichwörter der Autor:innen

Covid-19clinical trials of nicotine patchesnicotinic receptorssmoking

Substanzen

Nicotinic AgonistsReceptors, NicotinicNicotine

Autor:innen und Institutionen

  • Institut Pasteur CNRS UMR 3571 Department of Neuroscience and Collège de France, Paris France.
  • Sorbonne Université, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris).
  • Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Service de Médecine Interne 2, Maladies auto-immune et systémiques Institut E3M.
  • Institut Pasteur, Structural Virology Unit, Department of Virology, CNRS UMR 3569, Institut Pasteur Paris France.
  • Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, Département d'Immunologie, Paris, France.

ORCID-Profile: Jean-Pierre Changeux, Zahir Amoura

Zitieren

APA

Changeux, J. P., Amoura, Z., Rey, F. A., & Miyara, M. (2020). A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Comptes Rendus. Biologies, 343(1), 33-39. https://doi.org/10.5802/crbiol.8

Vancouver

Changeux JP, Amoura Z, Rey FA, Miyara M. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Comptes Rendus. Biologies. 2020;343(1):33-39. doi:10.5802/crbiol.8

BibTeX
@article{Changeux2020,
  author = {Changeux, Jean-Pierre and Amoura, Zahir and Rey, Felix A and Miyara, Makoto},
  title = {A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications},
  journal = {Comptes Rendus. Biologies},
  year = {2020},
  volume = {343},
  number = {1},
  pages = {33--39},
  doi = {10.5802/crbiol.8}
}
Kostenlos starten →